Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Inventory: 2019-2025

Historic Inventory for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $7.7 million.

  • Burning Rock Biotech's Inventory fell 19.19% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 19.19%. This contributed to the annual value of $8.6 million for FY2024, which is 11.74% down from last year.
  • As of Q3 2025, Burning Rock Biotech's Inventory stood at $7.7 million, which was down 88.31% from $65.4 million recorded in Q1 2025.
  • Over the past 5 years, Burning Rock Biotech's Inventory peaked at $150.4 million during Q3 2022, and registered a low of $7.7 million during Q3 2025.
  • For the 3-year period, Burning Rock Biotech's Inventory averaged around $42.1 million, with its median value being $9.6 million (2023).
  • Its Inventory has fluctuated over the past 5 years, first soared by 737.11% in 2022, then plummeted by 92.32% in 2024.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Inventory stood at $19.3 million in 2021, then declined by 2.28% to $18.9 million in 2022, then tumbled by 48.55% to $9.7 million in 2023, then dropped by 11.74% to $8.6 million in 2024, then declined by 19.19% to $7.7 million in 2025.
  • Its Inventory stands at $7.7 million for Q3 2025, versus $65.4 million for Q1 2025 and $8.6 million for Q4 2024.